0001209191-19-004549.txt : 20190118 0001209191-19-004549.hdr.sgml : 20190118 20190118161331 ACCESSION NUMBER: 0001209191-19-004549 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190116 FILED AS OF DATE: 20190118 DATE AS OF CHANGE: 20190118 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kirson Eilon D. CENTRAL INDEX KEY: 0001654356 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 19533389 MAIL ADDRESS: STREET 1: TOPAZ BUILDING, MATAN CENTER CITY: HAIFA STATE: L3 ZIP: 31905 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-16 0 0001645113 NovoCure Ltd NVCR 0001654356 Kirson Eilon D. C/O NOVOCURE INC., VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Science Officer Ordinary Shares 2019-01-16 4 M 0 100000 14.37 A 209063 D Ordinary Shares 2019-01-16 4 S 0 100000 45.11 D 109063 D Ordinary Shares 2019-01-17 4 M 0 68813 14.37 A 177876 D Ordinary Shares 2019-01-17 4 S 0 68813 45.25 D 109063 D Options to Buy Ordinary Shares 14.37 2019-01-16 4 M 0 100000 0.00 D 2025-02-23 Ordinary Shares 100000 135335 D Options to Buy Ordinary Shares 14.37 2019-01-17 4 M 0 68813 0.00 D 2025-02-23 Ordinary Shares 68813 66522 D Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson. On January 16, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 100,000 shares in multiple trades at prices ranging from $45.00 to $45.36. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On January 17, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson, Mr. Kirson sold 68,813 shares in multiple trades at prices ranging from $45.00 to $45.66. The price reported above reflects the weighted average sale price. Mr. Kirson hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Fully vested and currently exercisable as of the date hereof. By: /s/ Kimberly Burke, Attorney in fact for Eilon D. Kirson 2019-01-18